{"transactions":[{"id":4623425,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-21T20:33:26.000Z","date":"2026-09-17","kind":"gift","planned":false,"acquired":false,"shares":20445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 17th, the reporting person transferred 20,445 shares of Class A Common Stock to a trust for no consideration. The Reporting person is trustee of the trust."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"On September 17th, the reporting person transferred 20,445 shares of Class A Common Stock to a trust for no consideration. The Reporting person is trustee of the trust."}],"balance_after":75077,"source":{"system":"sec-edgar","filing":"0001628280-26-062915","document":"wk-form4_1790022803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026062915/wk-form4_1790022803.xml","form_type":"4"}},{"id":4616847,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-09-14T20:10:38.000Z","date":"2026-09-11","kind":"exercise","planned":false,"acquired":false,"shares":20445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is vested and currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":14.45,"expiration_date":"2026-11-23","underlying":"Class A Common Stock","underlying_shares":20445},"source":{"system":"sec-edgar","filing":"0001628280-26-061836","document":"wk-form4_1789416635.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026061836/wk-form4_1789416635.xml","form_type":"4"}},{"id":4616846,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-14T20:10:38.000Z","date":"2026-09-11","kind":"exercise","planned":false,"acquired":true,"shares":20445,"price":14.45,"value":295430.25,"ownership":{"direct":true},"balance_after":95522,"source":{"system":"sec-edgar","filing":"0001628280-26-061836","document":"wk-form4_1789416635.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026061836/wk-form4_1789416635.xml","form_type":"4"}},{"id":943,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-09-02T21:03:34.000Z","date":"2026-09-01","kind":"gift","planned":false,"acquired":false,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift to trust for the benefit of certain family members whereby reporting person does not serve as trustee."}],"balance_after":193646,"source":{"system":"sec-edgar","filing":"0001628280-26-060179","document":"wk-form4_1788383011.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026060179/wk-form4_1788383011.xml","form_type":"4"}},{"id":676183,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-08-25T20:41:33.000Z","date":"2026-08-21","kind":"gift","planned":false,"acquired":false,"shares":152426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift to trust for the benefit of certain family members whereby reporting person does not serve as trustee."}],"balance_after":273646,"source":{"system":"sec-edgar","filing":"0001628280-26-058918","document":"wk-form4_1787690491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026058918/wk-form4_1787690491.xml","form_type":"4"}},{"id":686977,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23363,"kind":"person","name":"Kiely John","position":1,"cik":"0001781149","reported_name":"Kiely John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-14T20:29:24.000Z","date":"2026-08-13","kind":"gift","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a charitable donation of common stock to a donor advised fund."}],"balance_after":200252,"source":{"system":"sec-edgar","filing":"0001628280-26-057147","document":"wk-form4_1786739361.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1781149/000162828026057147/wk-form4_1786739361.xml","form_type":"4"}},{"id":686976,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23363,"kind":"person","name":"Kiely John","position":1,"cik":"0001781149","reported_name":"Kiely John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-14T20:29:24.000Z","date":"2026-08-13","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":17.64,"value":882000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.26 to $17.88 per share, inclusive. The Reporting Person\nundertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the ranges set forth in the footnote."}],"balance_after":210252,"source":{"system":"sec-edgar","filing":"0001628280-26-057147","document":"wk-form4_1786739361.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781149/000162828026057147/wk-form4_1786739361.xml","form_type":"4"}},{"id":688024,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23706,"kind":"person","name":"Shah Nikita","position":1,"cik":"0001738061","reported_name":"Shah Nikita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-08-13T20:22:00.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":146403,"price":17.51,"value":2563516.53,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.40 to $17.67 per share, inclusive. The Reporting Person\nundertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the ranges set forth in the footnote."}],"balance_after":253390,"source":{"system":"sec-edgar","filing":"0001628280-26-056757","document":"wk-form4_1786652518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026056757/wk-form4_1786652518.xml","form_type":"4"}},{"id":688023,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23705,"kind":"person","name":"Daly Jason B.","position":1,"cik":"0001906486","reported_name":"Daly Jason B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-13T20:21:37.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":210000,"price":17.4,"value":3654000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.25 to $17.67 per share, inclusive. The Reporting Person\nundertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the ranges set forth in the footnote."}],"balance_after":35171,"source":{"system":"sec-edgar","filing":"0001628280-26-056754","document":"wk-form4_1786652494.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026056754/wk-form4_1786652494.xml","form_type":"4"}},{"id":688022,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23705,"kind":"person","name":"Daly Jason B.","position":1,"cik":"0001906486","reported_name":"Daly Jason B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-13T20:21:37.000Z","date":"2026-08-11","kind":"sale","planned":false,"acquired":false,"shares":6613,"price":17.7,"value":117050.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.65 to $17.73 per share, inclusive. The Reporting Person\nundertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the ranges set forth in the footnote."}],"balance_after":245171,"source":{"system":"sec-edgar","filing":"0001628280-26-056754","document":"wk-form4_1786652494.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026056754/wk-form4_1786652494.xml","form_type":"4"}},{"id":688021,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-13T20:21:02.000Z","date":"2026-08-11","kind":"exercise","planned":false,"acquired":false,"shares":168573,"price":17.18,"value":2896084.14,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.07 to $17.31 per share, inclusive. The Reporting Person\nundertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the ranges set forth in the footnote."}],"balance_after":93499,"source":{"system":"sec-edgar","filing":"0001628280-26-056752","document":"wk-form4_1786652460.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026056752/wk-form4_1786652460.xml","form_type":"4"}},{"id":689284,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24132,"kind":"person","name":"Patel Tushar Bhikhubhai","position":1,"cik":"0001745375","reported_name":"Patel Tushar Bhikhubhai","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-12T22:06:35.000Z","date":"2026-08-10","kind":"grant","planned":false,"acquired":true,"shares":12763469,"ownership":{"direct":false,"nature":"By Limited Liability Companies Controlled by Family Trusts"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 10, 2026, pursuant to a Membership Interest Purchase Agreement, dated as of April 21, 2026 (as amended from time to time, the \"Purchase Agreement\"), by and among the Issuer, Kashiv BioSciences, LLC (\"Kashiv\"), KB Seller Representative, LLC and the equityholders of Kashiv named therein (the \"Sellers\"), a subsidiary of the Issuer purchased (the \"Acquisition\") from the Sellers 100% of the issued and outstanding membership interests of Kashiv for an aggregate consideration of $375,000,000 in cash, subject to certain purchase price adjustments, and 28,942,098 shares of Issuer Class A common stock (\"Class A Common Stock\").  Pursuant to the terms of the Purchase Agreement, a limited liability company managed by the Reporting Person received 12,763,469 shares of Class A Common Stock in the Acquisition."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 10, 2026, pursuant to a Membership Interest Purchase Agreement, dated as of April 21, 2026 (as amended from time to time, the \"Purchase Agreement\"), by and among the Issuer, Kashiv BioSciences, LLC (\"Kashiv\"), KB Seller Representative, LLC and the equityholders of Kashiv named therein (the \"Sellers\"), a subsidiary of the Issuer purchased (the \"Acquisition\") from the Sellers 100% of the issued and outstanding membership interests of Kashiv for an aggregate consideration of $375,000,000 in cash, subject to certain purchase price adjustments, and 28,942,098 shares of Issuer Class A common stock (\"Class A Common Stock\").  Pursuant to the terms of the Purchase Agreement, a limited liability company managed by the Reporting Person received 12,763,469 shares of Class A Common Stock in the Acquisition."}],"balance_after":61341678,"source":{"system":"sec-edgar","filing":"0000898432-26-000655","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089843226000655/form4.xml","form_type":"4"}},{"id":689289,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24134,"kind":"person","name":"Patel Chintu","position":1,"cik":"0001737428","reported_name":"Patel Chintu","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-08-12T20:46:36.000Z","date":"2026-08-10","kind":"grant","planned":false,"acquired":true,"shares":6381734,"ownership":{"direct":false,"nature":"By Limited Liability Companies"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 10, 2026, pursuant to a Membership Interest Purchase Agreement, dated as of April 21, 2026 (as amended from time to time, the Purchase Agreement), by and among the Issuer, Kashiv BioSciences, LLC (Kashiv), KB Seller Representative, LLC and the equity holders of Kashiv named therein (the Sellers), a subsidiary of the Issuer purchased (the Acquisition) from the Sellers 100% of the issued and outstanding membership interests of Kashiv for an aggregate consideration of $375,000,000 in cash, subject to certain purchase price adjustments, and 28,942,098 shares of Issuer Class A common stock (Class A Common Stock). Pursuant to the terms of the Purchase Agreement, limited liability companies managed by the Reporting Person received 6,381,734 shares of Class A Common Stock in the Acquisition."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 10, 2026, pursuant to a Membership Interest Purchase Agreement, dated as of April 21, 2026 (as amended from time to time, the Purchase Agreement), by and among the Issuer, Kashiv BioSciences, LLC (Kashiv), KB Seller Representative, LLC and the equity holders of Kashiv named therein (the Sellers), a subsidiary of the Issuer purchased (the Acquisition) from the Sellers 100% of the issued and outstanding membership interests of Kashiv for an aggregate consideration of $375,000,000 in cash, subject to certain purchase price adjustments, and 28,942,098 shares of Issuer Class A common stock (Class A Common Stock). Pursuant to the terms of the Purchase Agreement, limited liability companies managed by the Reporting Person received 6,381,734 shares of Class A Common Stock in the Acquisition."}],"balance_after":6381734,"source":{"system":"sec-edgar","filing":"0001628280-26-056297","document":"wk-form4_1786567594.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737428/000162828026056297/wk-form4_1786567594.xml","form_type":"4"}},{"id":689283,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-12T20:39:55.000Z","date":"2026-08-10","kind":"grant","planned":false,"acquired":true,"shares":283632,"ownership":{"direct":false,"nature":"By Limited Liability Company"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 10, 2026, pursuant to a Membership Interest Purchase Agreement, dated as of April 21, 2026 (as amended from time to time, the Purchase Agreement), by and among the Issuer, Kashiv BioSciences, LLC (Kashiv), KB Seller Representative, LLC and the equity holders of Kashiv named therein (the Sellers), a subsidiary of the Issuer purchased (the Acquisition) from the Sellers 100% of the issued and outstanding membership interests of Kashiv for an aggregate consideration of $375,000,000 in cash, subject to certain purchase price adjustments, and 28,942,098 shares of Issuer Class A common stock (Class A Common Stock). Pursuant to the terms of the Purchase Agreement, limited liability companies managed by the Reporting Person received 283,632 shares of Class A Common Stock in the Acquisition."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 10, 2026, pursuant to a Membership Interest Purchase Agreement, dated as of April 21, 2026 (as amended from time to time, the Purchase Agreement), by and among the Issuer, Kashiv BioSciences, LLC (Kashiv), KB Seller Representative, LLC and the equity holders of Kashiv named therein (the Sellers), a subsidiary of the Issuer purchased (the Acquisition) from the Sellers 100% of the issued and outstanding membership interests of Kashiv for an aggregate consideration of $375,000,000 in cash, subject to certain purchase price adjustments, and 28,942,098 shares of Issuer Class A common stock (Class A Common Stock). Pursuant to the terms of the Purchase Agreement, limited liability companies managed by the Reporting Person received 283,632 shares of Class A Common Stock in the Acquisition."}],"balance_after":283632,"source":{"system":"sec-edgar","filing":"0001628280-26-056288","document":"wk-form4_1786567192.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026056288/wk-form4_1786567192.xml","form_type":"4"}},{"id":689279,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-08-12T20:37:56.000Z","date":"2026-08-10","kind":"grant","planned":false,"acquired":true,"shares":6381734,"ownership":{"direct":false,"nature":"By Limited Liability Companies"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 10, 2026, pursuant to a Membership Interest Purchase Agreement, dated as of April 21, 2026 (as amended from time to time, the Purchase Agreement), by and among the Issuer, Kashiv BioSciences, LLC (Kashiv), KB Seller Representative, LLC and the equity holders of Kashiv named therein (the Sellers), a subsidiary of the Issuer purchased (the Acquisition) from the Sellers 100% of the issued and outstanding membership interests of Kashiv for an aggregate consideration of $375,000,000 in cash, subject to certain purchase price adjustments, and 28,942,098 shares of Issuer Class A common stock (Class A Common Stock).  Pursuant to the terms of the Purchase Agreement, limited liability companies managed by the Reporting Person received 6,381,734 shares of Class A Common Stock in the Acquisition."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 10, 2026, pursuant to a Membership Interest Purchase Agreement, dated as of April 21, 2026 (as amended from time to time, the Purchase Agreement), by and among the Issuer, Kashiv BioSciences, LLC (Kashiv), KB Seller Representative, LLC and the equity holders of Kashiv named therein (the Sellers), a subsidiary of the Issuer purchased (the Acquisition) from the Sellers 100% of the issued and outstanding membership interests of Kashiv for an aggregate consideration of $375,000,000 in cash, subject to certain purchase price adjustments, and 28,942,098 shares of Issuer Class A common stock (Class A Common Stock).  Pursuant to the terms of the Purchase Agreement, limited liability companies managed by the Reporting Person received 6,381,734 shares of Class A Common Stock in the Acquisition."}],"balance_after":6381734,"source":{"system":"sec-edgar","filing":"0001628280-26-056285","document":"wk-form4_1786567073.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026056285/wk-form4_1786567073.xml","form_type":"4"}},{"id":782726,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":21279,"kind":"person","name":"Autor Deborah M.","position":1,"cik":"0001884671","reported_name":"Autor Deborah M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-12T20:10:27.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":34819,"price":12.94,"value":450557.86,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.75 to $13.27 per share, inclusive. The Reporting Person\nundertakes to provide Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the ranges set forth in this footnote."}],"balance_after":93660,"source":{"system":"sec-edgar","filing":"0001628280-26-034106","document":"wk-form4_1778616625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1884671/000162828026034106/wk-form4_1778616625.xml","form_type":"4"}},{"id":786874,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:29:14.000Z","date":"2026-05-06","kind":"grant","planned":false,"acquired":true,"shares":19824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":19824,"derivative":{"underlying":"Class A Common Stock","underlying_shares":19824},"source":{"system":"sec-edgar","filing":"0001628280-26-032929","document":"wk-form4_1778272151.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032929/wk-form4_1778272151.xml","form_type":"4"}},{"id":786873,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:29:14.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":34819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":34819},"source":{"system":"sec-edgar","filing":"0001628280-26-032929","document":"wk-form4_1778272151.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032929/wk-form4_1778272151.xml","form_type":"4"}},{"id":786872,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-08T20:29:14.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":34819,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":75077,"source":{"system":"sec-edgar","filing":"0001628280-26-032929","document":"wk-form4_1778272151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032929/wk-form4_1778272151.xml","form_type":"4"}},{"id":787024,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":21279,"kind":"person","name":"Autor Deborah M.","position":1,"cik":"0001884671","reported_name":"Autor Deborah M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:28:25.000Z","date":"2026-05-06","kind":"grant","planned":false,"acquired":true,"shares":19824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":19824,"derivative":{"underlying":"Class A Common Stock","underlying_shares":19824},"source":{"system":"sec-edgar","filing":"0001628280-26-032925","document":"wk-form4_1778272102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1884671/000162828026032925/wk-form4_1778272102.xml","form_type":"4"}},{"id":787023,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":21279,"kind":"person","name":"Autor Deborah M.","position":1,"cik":"0001884671","reported_name":"Autor Deborah M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:28:25.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":34819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":34819},"source":{"system":"sec-edgar","filing":"0001628280-26-032925","document":"wk-form4_1778272102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1884671/000162828026032925/wk-form4_1778272102.xml","form_type":"4"}},{"id":787022,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":21279,"kind":"person","name":"Autor Deborah M.","position":1,"cik":"0001884671","reported_name":"Autor Deborah M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-08T20:28:25.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":34819,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":128479,"source":{"system":"sec-edgar","filing":"0001628280-26-032925","document":"wk-form4_1778272102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1884671/000162828026032925/wk-form4_1778272102.xml","form_type":"4"}},{"id":786922,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":38205,"kind":"person","name":"George Jeffrey P.","position":1,"cik":"0001796789","reported_name":"George Jeffrey P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:27:33.000Z","date":"2026-05-06","kind":"grant","planned":false,"acquired":true,"shares":19824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":19824,"derivative":{"underlying":"Class A Common Stock","underlying_shares":19824},"source":{"system":"sec-edgar","filing":"0001628280-26-032924","document":"wk-form4_1778272051.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1796789/000162828026032924/wk-form4_1778272051.xml","form_type":"4"}},{"id":786921,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":38205,"kind":"person","name":"George Jeffrey P.","position":1,"cik":"0001796789","reported_name":"George Jeffrey P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:27:33.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":34819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":34819},"source":{"system":"sec-edgar","filing":"0001628280-26-032924","document":"wk-form4_1778272051.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1796789/000162828026032924/wk-form4_1778272051.xml","form_type":"4"}},{"id":786920,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":38205,"kind":"person","name":"George Jeffrey P.","position":1,"cik":"0001796789","reported_name":"George Jeffrey P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-08T20:27:33.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":34819,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":344614,"source":{"system":"sec-edgar","filing":"0001628280-26-032924","document":"wk-form4_1778272051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1796789/000162828026032924/wk-form4_1778272051.xml","form_type":"4"}},{"id":786871,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:26:47.000Z","date":"2026-05-06","kind":"grant","planned":false,"acquired":true,"shares":19824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":19824,"derivative":{"underlying":"Class A Common Stock","underlying_shares":19824},"source":{"system":"sec-edgar","filing":"0001628280-26-032922","document":"wk-form4_1778272004.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032922/wk-form4_1778272004.xml","form_type":"4"}},{"id":786870,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:26:47.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":34819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":34819},"source":{"system":"sec-edgar","filing":"0001628280-26-032922","document":"wk-form4_1778272004.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032922/wk-form4_1778272004.xml","form_type":"4"}},{"id":786869,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24131,"kind":"person","name":"Patel Gautam","position":1,"cik":"0001738054","reported_name":"Patel Gautam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-08T20:26:47.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":34819,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":1643963,"source":{"system":"sec-edgar","filing":"0001628280-26-032922","document":"wk-form4_1778272004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032922/wk-form4_1778272004.xml","form_type":"4"}},{"id":786919,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23363,"kind":"person","name":"Kiely John","position":1,"cik":"0001781149","reported_name":"Kiely John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:24:19.000Z","date":"2026-05-06","kind":"grant","planned":false,"acquired":true,"shares":19824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":19824,"derivative":{"underlying":"Class A Common Stock","underlying_shares":19824},"source":{"system":"sec-edgar","filing":"0001628280-26-032911","document":"wk-form4_1778271857.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1781149/000162828026032911/wk-form4_1778271857.xml","form_type":"4"}},{"id":786918,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23363,"kind":"person","name":"Kiely John","position":1,"cik":"0001781149","reported_name":"Kiely John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:24:19.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":34819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":34819},"source":{"system":"sec-edgar","filing":"0001628280-26-032911","document":"wk-form4_1778271857.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1781149/000162828026032911/wk-form4_1778271857.xml","form_type":"4"}},{"id":786917,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23363,"kind":"person","name":"Kiely John","position":1,"cik":"0001781149","reported_name":"Kiely John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-08T20:24:19.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":34819,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":260252,"source":{"system":"sec-edgar","filing":"0001628280-26-032911","document":"wk-form4_1778271857.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781149/000162828026032911/wk-form4_1778271857.xml","form_type":"4"}},{"id":786868,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:23:39.000Z","date":"2026-05-06","kind":"grant","planned":false,"acquired":true,"shares":19824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":19824,"derivative":{"underlying":"Class A Common Stock","underlying_shares":19824},"source":{"system":"sec-edgar","filing":"0001628280-26-032910","document":"wk-form4_1778271816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032910/wk-form4_1778271816.xml","form_type":"4"}},{"id":786867,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:23:39.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":34819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":34819},"source":{"system":"sec-edgar","filing":"0001628280-26-032910","document":"wk-form4_1778271816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032910/wk-form4_1778271816.xml","form_type":"4"}},{"id":786866,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":48727,"kind":"person","name":"Nark Ted C","position":1,"cik":"0001316851","reported_name":"Nark Ted C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-08T20:23:39.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":34819,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":325848,"source":{"system":"sec-edgar","filing":"0001628280-26-032910","document":"wk-form4_1778271816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032910/wk-form4_1778271816.xml","form_type":"4"}},{"id":787286,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":17353,"kind":"person","name":"MEISTER PAUL M","position":1,"cik":"0001033876","reported_name":"MEISTER PAUL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:22:55.000Z","date":"2026-05-06","kind":"grant","planned":false,"acquired":true,"shares":30837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":30837,"derivative":{"underlying":"Class A Common Stock","underlying_shares":30837},"source":{"system":"sec-edgar","filing":"0001628280-26-032907","document":"wk-form4_1778271772.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1033876/000162828026032907/wk-form4_1778271772.xml","form_type":"4"}},{"id":787285,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":17353,"kind":"person","name":"MEISTER PAUL M","position":1,"cik":"0001033876","reported_name":"MEISTER PAUL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:22:55.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":48747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 48,747 restricted stock units vesting on May 7, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 48,747 restricted stock units vesting on May 7, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":48747},"source":{"system":"sec-edgar","filing":"0001628280-26-032907","document":"wk-form4_1778271772.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1033876/000162828026032907/wk-form4_1778271772.xml","form_type":"4"}},{"id":787284,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":17353,"kind":"person","name":"MEISTER PAUL M","position":1,"cik":"0001033876","reported_name":"MEISTER PAUL M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-08T20:22:55.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":48747,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":832800,"source":{"system":"sec-edgar","filing":"0001628280-26-032907","document":"wk-form4_1778271772.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1033876/000162828026032907/wk-form4_1778271772.xml","form_type":"4"}},{"id":786859,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:22:08.000Z","date":"2026-05-06","kind":"grant","planned":false,"acquired":true,"shares":19824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":19824,"derivative":{"underlying":"Class A Common Stock","underlying_shares":19824},"source":{"system":"sec-edgar","filing":"0001628280-26-032904","document":"wk-form4_1778271725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032904/wk-form4_1778271725.xml","form_type":"4"}},{"id":786858,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:22:08.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":34819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":34819},"source":{"system":"sec-edgar","filing":"0001628280-26-032904","document":"wk-form4_1778271725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032904/wk-form4_1778271725.xml","form_type":"4"}},{"id":786857,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":10850,"kind":"person","name":"Yanai Shlomo","position":1,"cik":"0001562645","reported_name":"Yanai Shlomo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-08T20:22:08.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":34819,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":320804,"source":{"system":"sec-edgar","filing":"0001628280-26-032904","document":"wk-form4_1778271725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032904/wk-form4_1778271725.xml","form_type":"4"}},{"id":826402,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24134,"kind":"person","name":"Patel Chintu","position":1,"cik":"0001737428","reported_name":"Patel Chintu","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-CEO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2026-03-27T20:20:46.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":544663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a performance-based restricted stock unit grant of 544,663 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2029, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents a performance-based restricted stock unit grant of 544,663 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2029, the last day of the performance period."}],"balance_after":544663,"derivative":{"underlying":"Class A Common Stock","underlying_shares":544663},"source":{"system":"sec-edgar","filing":"0001628280-26-021746","document":"wk-form4a_1774642844.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737428/000162828026021746/wk-form4a_1774642844.xml","form_type":"4/A","original_submission_date":"2026-03-03"}},{"id":826395,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2026-03-27T20:19:46.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":544663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a performance-based restricted stock unit grant of 544,663 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2029, the last day of the performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents a performance-based restricted stock unit grant of 544,663 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing price per share targets at the end of the three-year performance period. The number of shares that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2029, the last day of the performance period."}],"balance_after":544663,"derivative":{"underlying":"Class A Common Stock","underlying_shares":544663},"source":{"system":"sec-edgar","filing":"0001628280-26-021742","document":"wk-form4a_1774642784.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026021742/wk-form4a_1774642784.xml","form_type":"4/A","original_submission_date":"2026-03-03"}},{"id":858647,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24134,"kind":"person","name":"Patel Chintu","position":1,"cik":"0001737428","reported_name":"Patel Chintu","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:52:25.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":false,"shares":92593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On March 4, 2024, the reporting person was granted 370,370 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On March 4, 2024, the reporting person was granted 370,370 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":185185,"derivative":{"underlying":"Class A Common Stock","underlying_shares":92593},"source":{"system":"sec-edgar","filing":"0001628280-26-015285","document":"wk-form4_1772747542.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1737428/000162828026015285/wk-form4_1772747542.xml","form_type":"4"}},{"id":858646,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24134,"kind":"person","name":"Patel Chintu","position":1,"cik":"0001737428","reported_name":"Patel Chintu","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-CEO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2026-03-05T21:52:25.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":733944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":733944},"source":{"system":"sec-edgar","filing":"0001628280-26-015285","document":"wk-form4_1772747542.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1737428/000162828026015285/wk-form4_1772747542.xml","form_type":"4"}},{"id":858645,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24134,"kind":"person","name":"Patel Chintu","position":1,"cik":"0001737428","reported_name":"Patel Chintu","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:52:25.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":59931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 3, 2025, the Reporting Person was granted 239,726 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 3, 2025, the Reporting Person was granted 239,726 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":179795,"derivative":{"underlying":"Class A Common Stock","underlying_shares":59931},"source":{"system":"sec-edgar","filing":"0001628280-26-015285","document":"wk-form4_1772747542.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1737428/000162828026015285/wk-form4_1772747542.xml","form_type":"4"}},{"id":858644,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24134,"kind":"person","name":"Patel Chintu","position":1,"cik":"0001737428","reported_name":"Patel Chintu","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:52:25.000Z","date":"2026-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":28983,"price":13.3,"value":385473.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":1388521,"source":{"system":"sec-edgar","filing":"0001628280-26-015285","document":"wk-form4_1772747542.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1737428/000162828026015285/wk-form4_1772747542.xml","form_type":"4"}},{"id":858643,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24134,"kind":"person","name":"Patel Chintu","position":1,"cik":"0001737428","reported_name":"Patel Chintu","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:52:25.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":true,"shares":92593,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":1417504,"source":{"system":"sec-edgar","filing":"0001628280-26-015285","document":"wk-form4_1772747542.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1737428/000162828026015285/wk-form4_1772747542.xml","form_type":"4"}},{"id":858642,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24134,"kind":"person","name":"Patel Chintu","position":1,"cik":"0001737428","reported_name":"Patel Chintu","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:52:25.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":315885,"price":13.31,"value":4204429.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to vesting of performance-based restricted stock units."}],"balance_after":1324911,"source":{"system":"sec-edgar","filing":"0001628280-26-015285","document":"wk-form4_1772747542.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1737428/000162828026015285/wk-form4_1772747542.xml","form_type":"4"}},{"id":858641,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24134,"kind":"person","name":"Patel Chintu","position":1,"cik":"0001737428","reported_name":"Patel Chintu","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:52:25.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":733944,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."}],"balance_after":1640796,"source":{"system":"sec-edgar","filing":"0001628280-26-015285","document":"wk-form4_1772747542.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737428/000162828026015285/wk-form4_1772747542.xml","form_type":"4"}},{"id":858640,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24134,"kind":"person","name":"Patel Chintu","position":1,"cik":"0001737428","reported_name":"Patel Chintu","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:52:25.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":17112,"price":13.31,"value":227760.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":906852,"source":{"system":"sec-edgar","filing":"0001628280-26-015285","document":"wk-form4_1772747542.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737428/000162828026015285/wk-form4_1772747542.xml","form_type":"4"}},{"id":858639,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24134,"kind":"person","name":"Patel Chintu","position":1,"cik":"0001737428","reported_name":"Patel Chintu","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:52:25.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":59931,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":923964,"source":{"system":"sec-edgar","filing":"0001628280-26-015285","document":"wk-form4_1772747542.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737428/000162828026015285/wk-form4_1772747542.xml","form_type":"4"}},{"id":858627,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:51:58.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":false,"shares":92593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On March 4, 2024, the reporting person was granted 370,370 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On March 4, 2024, the reporting person was granted 370,370 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":185185,"derivative":{"underlying":"Class A Common Stock","underlying_shares":92593},"source":{"system":"sec-edgar","filing":"0001628280-26-015283","document":"wk-form4_1772747515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015283/wk-form4_1772747515.xml","form_type":"4"}},{"id":858626,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2026-03-05T21:51:58.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":733944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":733944},"source":{"system":"sec-edgar","filing":"0001628280-26-015283","document":"wk-form4_1772747515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015283/wk-form4_1772747515.xml","form_type":"4"}},{"id":858625,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:51:58.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":59931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 3, 2025, the Reporting Person was granted 239,726 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 3, 2025, the Reporting Person was granted 239,726 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":179795,"derivative":{"underlying":"Class A Common Stock","underlying_shares":59931},"source":{"system":"sec-edgar","filing":"0001628280-26-015283","document":"wk-form4_1772747515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015283/wk-form4_1772747515.xml","form_type":"4"}},{"id":858624,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:51:58.000Z","date":"2026-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":37825,"price":13.3,"value":503072.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":1393470,"source":{"system":"sec-edgar","filing":"0001628280-26-015283","document":"wk-form4_1772747515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015283/wk-form4_1772747515.xml","form_type":"4"}},{"id":858623,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:51:58.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":true,"shares":92593,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":1431295,"source":{"system":"sec-edgar","filing":"0001628280-26-015283","document":"wk-form4_1772747515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015283/wk-form4_1772747515.xml","form_type":"4"}},{"id":858622,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:51:58.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":297537,"price":13.31,"value":3960217.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units."}],"balance_after":1338702,"source":{"system":"sec-edgar","filing":"0001628280-26-015283","document":"wk-form4_1772747515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015283/wk-form4_1772747515.xml","form_type":"4"}},{"id":858621,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:51:58.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":733944,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."}],"balance_after":1636239,"source":{"system":"sec-edgar","filing":"0001628280-26-015283","document":"wk-form4_1772747515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015283/wk-form4_1772747515.xml","form_type":"4"}},{"id":858620,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:51:58.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":15616,"price":13.31,"value":207848.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":902295,"source":{"system":"sec-edgar","filing":"0001628280-26-015283","document":"wk-form4_1772747515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015283/wk-form4_1772747515.xml","form_type":"4"}},{"id":858619,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":24129,"kind":"person","name":"Patel Chirag K.","position":1,"cik":"0001738701","reported_name":"Patel Chirag K.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Co-CEO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:51:58.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":59931,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":917911,"source":{"system":"sec-edgar","filing":"0001628280-26-015283","document":"wk-form4_1772747515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015283/wk-form4_1772747515.xml","form_type":"4"}},{"id":858618,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23705,"kind":"person","name":"Daly Jason B.","position":1,"cik":"0001906486","reported_name":"Daly Jason B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:32:25.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":false,"shares":35880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On March 4, 2024, the reporting person was granted 143,519 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On March 4, 2024, the reporting person was granted 143,519 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":71760,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35880},"source":{"system":"sec-edgar","filing":"0001628280-26-015241","document":"wk-form4_1772746340.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015241/wk-form4_1772746340.xml","form_type":"4"}},{"id":858617,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23705,"kind":"person","name":"Daly Jason B.","position":1,"cik":"0001906486","reported_name":"Daly Jason B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2026-03-05T21:32:25.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":305810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":305810},"source":{"system":"sec-edgar","filing":"0001628280-26-015241","document":"wk-form4_1772746340.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015241/wk-form4_1772746340.xml","form_type":"4"}},{"id":858616,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23705,"kind":"person","name":"Daly Jason B.","position":1,"cik":"0001906486","reported_name":"Daly Jason B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:32:25.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":24258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On March 3, 2025, the reporting person was granted 97,032 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On March 3, 2025, the reporting person was granted 97,032 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":72774,"derivative":{"underlying":"Class A Common Stock","underlying_shares":24258},"source":{"system":"sec-edgar","filing":"0001628280-26-015241","document":"wk-form4_1772746340.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015241/wk-form4_1772746340.xml","form_type":"4"}},{"id":858615,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23705,"kind":"person","name":"Daly Jason B.","position":1,"cik":"0001906486","reported_name":"Daly Jason B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:32:25.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":38226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On March 3, 2023, the reporting person was granted 152,905 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On March 3, 2023, the reporting person was granted 152,905 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":38227,"derivative":{"underlying":"Class A Common Stock","underlying_shares":38226},"source":{"system":"sec-edgar","filing":"0001628280-26-015241","document":"wk-form4_1772746340.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015241/wk-form4_1772746340.xml","form_type":"4"}},{"id":858614,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23705,"kind":"person","name":"Daly Jason B.","position":1,"cik":"0001906486","reported_name":"Daly Jason B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:32:25.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":22645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 3, 2022, the reporting person was granted 90,580 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 3, 2022, the reporting person was granted 90,580 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":22645},"source":{"system":"sec-edgar","filing":"0001628280-26-015241","document":"wk-form4_1772746340.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015241/wk-form4_1772746340.xml","form_type":"4"}},{"id":858613,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23705,"kind":"person","name":"Daly Jason B.","position":1,"cik":"0001906486","reported_name":"Daly Jason B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:32:25.000Z","date":"2026-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":15580,"price":13.3,"value":207214.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":251784,"source":{"system":"sec-edgar","filing":"0001628280-26-015241","document":"wk-form4_1772746340.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015241/wk-form4_1772746340.xml","form_type":"4"}},{"id":858612,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23705,"kind":"person","name":"Daly Jason B.","position":1,"cik":"0001906486","reported_name":"Daly Jason B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:32:25.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":true,"shares":35880,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":267364,"source":{"system":"sec-edgar","filing":"0001628280-26-015241","document":"wk-form4_1772746340.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015241/wk-form4_1772746340.xml","form_type":"4"}},{"id":858611,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23705,"kind":"person","name":"Daly Jason B.","position":1,"cik":"0001906486","reported_name":"Daly Jason B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:32:25.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":132783,"price":13.31,"value":1767341.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units."}],"balance_after":231484,"source":{"system":"sec-edgar","filing":"0001628280-26-015241","document":"wk-form4_1772746340.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015241/wk-form4_1772746340.xml","form_type":"4"}},{"id":858610,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23705,"kind":"person","name":"Daly Jason B.","position":1,"cik":"0001906486","reported_name":"Daly Jason B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:32:25.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":305810,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."}],"balance_after":364267,"source":{"system":"sec-edgar","filing":"0001628280-26-015241","document":"wk-form4_1772746340.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015241/wk-form4_1772746340.xml","form_type":"4"}},{"id":858609,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23705,"kind":"person","name":"Daly Jason B.","position":1,"cik":"0001906486","reported_name":"Daly Jason B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:32:25.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":10533,"price":13.31,"value":140194.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":58457,"source":{"system":"sec-edgar","filing":"0001628280-26-015241","document":"wk-form4_1772746340.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015241/wk-form4_1772746340.xml","form_type":"4"}},{"id":858608,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23705,"kind":"person","name":"Daly Jason B.","position":1,"cik":"0001906486","reported_name":"Daly Jason B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:32:25.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":24258,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":68990,"source":{"system":"sec-edgar","filing":"0001628280-26-015241","document":"wk-form4_1772746340.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015241/wk-form4_1772746340.xml","form_type":"4"}},{"id":858607,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23705,"kind":"person","name":"Daly Jason B.","position":1,"cik":"0001906486","reported_name":"Daly Jason B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:32:25.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":16598,"price":13.31,"value":220919.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":44732,"source":{"system":"sec-edgar","filing":"0001628280-26-015241","document":"wk-form4_1772746340.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015241/wk-form4_1772746340.xml","form_type":"4"}},{"id":858606,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23705,"kind":"person","name":"Daly Jason B.","position":1,"cik":"0001906486","reported_name":"Daly Jason B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:32:25.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":38226,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":61330,"source":{"system":"sec-edgar","filing":"0001628280-26-015241","document":"wk-form4_1772746340.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015241/wk-form4_1772746340.xml","form_type":"4"}},{"id":858605,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23705,"kind":"person","name":"Daly Jason B.","position":1,"cik":"0001906486","reported_name":"Daly Jason B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:32:25.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":10147,"price":13.31,"value":135056.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":23104,"source":{"system":"sec-edgar","filing":"0001628280-26-015241","document":"wk-form4_1772746340.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015241/wk-form4_1772746340.xml","form_type":"4"}},{"id":858604,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23705,"kind":"person","name":"Daly Jason B.","position":1,"cik":"0001906486","reported_name":"Daly Jason B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:32:25.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":22645,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":33251,"source":{"system":"sec-edgar","filing":"0001628280-26-015241","document":"wk-form4_1772746340.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015241/wk-form4_1772746340.xml","form_type":"4"}},{"id":858603,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":62572,"kind":"person","name":"Konidaris Tasos","position":1,"cik":"0001320982","reported_name":"Konidaris Tasos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:31:57.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":false,"shares":49982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On March 4, 2024, the reporting person was granted 175,926 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On March 4, 2024, the reporting person was granted 175,926 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":87963,"derivative":{"underlying":"Class A Common Stock","underlying_shares":49982},"source":{"system":"sec-edgar","filing":"0001628280-26-015239","document":"wk-form4_1772746314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015239/wk-form4_1772746314.xml","form_type":"4"}},{"id":858602,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":62572,"kind":"person","name":"Konidaris Tasos","position":1,"cik":"0001320982","reported_name":"Konidaris Tasos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2026-03-05T21:31:57.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":458716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":458716},"source":{"system":"sec-edgar","filing":"0001628280-26-015239","document":"wk-form4_1772746314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015239/wk-form4_1772746314.xml","form_type":"4"}},{"id":858601,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":62572,"kind":"person","name":"Konidaris Tasos","position":1,"cik":"0001320982","reported_name":"Konidaris Tasos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:31:57.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":28538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On March 3, 2025, the reporting person was granted 114,155 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On March 3, 2025, the reporting person was granted 114,155 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":85617,"derivative":{"underlying":"Class A Common Stock","underlying_shares":28538},"source":{"system":"sec-edgar","filing":"0001628280-26-015239","document":"wk-form4_1772746314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015239/wk-form4_1772746314.xml","form_type":"4"}},{"id":858600,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":62572,"kind":"person","name":"Konidaris Tasos","position":1,"cik":"0001320982","reported_name":"Konidaris Tasos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:31:57.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":57339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On March 3, 2023, the reporting person was granted 229,358 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On March 3, 2023, the reporting person was granted 229,358 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":57340,"derivative":{"underlying":"Class A Common Stock","underlying_shares":57339},"source":{"system":"sec-edgar","filing":"0001628280-26-015239","document":"wk-form4_1772746314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015239/wk-form4_1772746314.xml","form_type":"4"}},{"id":858599,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":62572,"kind":"person","name":"Konidaris Tasos","position":1,"cik":"0001320982","reported_name":"Konidaris Tasos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:31:57.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":45290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 3, 2022, the reporting person was granted 181,159 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 3, 2022, the reporting person was granted 181,159 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":45290},"source":{"system":"sec-edgar","filing":"0001628280-26-015239","document":"wk-form4_1772746314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015239/wk-form4_1772746314.xml","form_type":"4"}},{"id":858598,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":62572,"kind":"person","name":"Konidaris Tasos","position":1,"cik":"0001320982","reported_name":"Konidaris Tasos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:57.000Z","date":"2026-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":22035,"price":13.3,"value":293065.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":449434,"source":{"system":"sec-edgar","filing":"0001628280-26-015239","document":"wk-form4_1772746314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015239/wk-form4_1772746314.xml","form_type":"4"}},{"id":858597,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":62572,"kind":"person","name":"Konidaris Tasos","position":1,"cik":"0001320982","reported_name":"Konidaris Tasos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:57.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":true,"shares":43982,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":471469,"source":{"system":"sec-edgar","filing":"0001628280-26-015239","document":"wk-form4_1772746314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015239/wk-form4_1772746314.xml","form_type":"4"}},{"id":858596,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":62572,"kind":"person","name":"Konidaris Tasos","position":1,"cik":"0001320982","reported_name":"Konidaris Tasos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:57.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":229817,"price":13.31,"value":3058864.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units."}],"balance_after":427487,"source":{"system":"sec-edgar","filing":"0001628280-26-015239","document":"wk-form4_1772746314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015239/wk-form4_1772746314.xml","form_type":"4"}},{"id":858595,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":62572,"kind":"person","name":"Konidaris Tasos","position":1,"cik":"0001320982","reported_name":"Konidaris Tasos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:57.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":458716,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."}],"balance_after":657304,"source":{"system":"sec-edgar","filing":"0001628280-26-015239","document":"wk-form4_1772746314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015239/wk-form4_1772746314.xml","form_type":"4"}},{"id":858594,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":62572,"kind":"person","name":"Konidaris Tasos","position":1,"cik":"0001320982","reported_name":"Konidaris Tasos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:57.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":14298,"price":13.31,"value":190306.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":198588,"source":{"system":"sec-edgar","filing":"0001628280-26-015239","document":"wk-form4_1772746314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015239/wk-form4_1772746314.xml","form_type":"4"}},{"id":858593,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":62572,"kind":"person","name":"Konidaris Tasos","position":1,"cik":"0001320982","reported_name":"Konidaris Tasos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:57.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":28538,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":212886,"source":{"system":"sec-edgar","filing":"0001628280-26-015239","document":"wk-form4_1772746314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015239/wk-form4_1772746314.xml","form_type":"4"}},{"id":858592,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":62572,"kind":"person","name":"Konidaris Tasos","position":1,"cik":"0001320982","reported_name":"Konidaris Tasos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:57.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":24251,"price":13.31,"value":322780.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":184348,"source":{"system":"sec-edgar","filing":"0001628280-26-015239","document":"wk-form4_1772746314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015239/wk-form4_1772746314.xml","form_type":"4"}},{"id":858591,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":62572,"kind":"person","name":"Konidaris Tasos","position":1,"cik":"0001320982","reported_name":"Konidaris Tasos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:57.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":57339,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":208599,"source":{"system":"sec-edgar","filing":"0001628280-26-015239","document":"wk-form4_1772746314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015239/wk-form4_1772746314.xml","form_type":"4"}},{"id":858590,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":62572,"kind":"person","name":"Konidaris Tasos","position":1,"cik":"0001320982","reported_name":"Konidaris Tasos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:57.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":16182,"price":13.31,"value":215382.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":151260,"source":{"system":"sec-edgar","filing":"0001628280-26-015239","document":"wk-form4_1772746314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015239/wk-form4_1772746314.xml","form_type":"4"}},{"id":858589,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":62572,"kind":"person","name":"Konidaris Tasos","position":1,"cik":"0001320982","reported_name":"Konidaris Tasos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:57.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":45290,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":167442,"source":{"system":"sec-edgar","filing":"0001628280-26-015239","document":"wk-form4_1772746314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015239/wk-form4_1772746314.xml","form_type":"4"}},{"id":858588,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":false,"shares":38195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On March 4, 2024, the reporting person was granted 152,778 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On March 4, 2024, the reporting person was granted 152,778 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":76389,"derivative":{"underlying":"Class A Common Stock","underlying_shares":38195},"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858587,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":397554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":397554},"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858586,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":24258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On March 3, 2025, the reporting person was granted 97,032 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On March 3, 2025, the reporting person was granted 97,032 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":72774,"derivative":{"underlying":"Class A Common Stock","underlying_shares":24258},"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858585,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":49694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On March 3, 2023, the reporting person was granted 198,777 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On March 3, 2023, the reporting person was granted 198,777 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":49695,"derivative":{"underlying":"Class A Common Stock","underlying_shares":49694},"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858584,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":39252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 4, 2022, the reporting person was granted 157,005 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 4, 2022, the reporting person was granted 157,005 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":39252},"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858583,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":19136,"price":13.3,"value":254508.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":426072,"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858582,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":true,"shares":38195,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":445208,"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858581,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":199175,"price":13.31,"value":2651019.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units."}],"balance_after":407013,"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858580,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":397554,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.  On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period.  These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis.  Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites.  The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations.  See footnote 5."}],"balance_after":606188,"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}},{"id":858579,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":821,"kind":"person","name":"BOYER ANDREW S","position":1,"cik":"0001239546","reported_name":"BOYER ANDREW S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Class A Common Stock","published_at":"2026-03-05T21:31:07.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":12154,"price":13.31,"value":161769.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units."}],"balance_after":208634,"source":{"system":"sec-edgar","filing":"0001628280-26-015238","document":"wk-form4_1772746263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026015238/wk-form4_1772746263.xml","form_type":"4"}}],"next_cursor":"2026-03-05T21:31:07.000000Z,858579"}